Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees.

MLA

Fung, Kin Wah, et al. “Tamsulosin Use in Benign Prostatic Hyperplasia and Risks of Parkinson’s Disease, Alzheimer’s Disease and Mortality: An Observational Cohort Study of Elderly Medicare Enrollees.” PloS One, vol. 19, no. 8, Aug. 2024, p. e0309222. EBSCOhost, https://doi.org/10.1371/journal.pone.0309222.

APA

Fung, K. W., Baye, F., Baik, S. H., & McDonald, C. J. (2024). Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson’s disease, Alzheimer’s disease and mortality: An observational cohort study of elderly Medicare enrollees. PloS One, 19(8), e0309222. https://doi.org/10.1371/journal.pone.0309222

Chicago

Fung, Kin Wah, Fitsum Baye, Seo H Baik, and Clement J McDonald. 2024. “Tamsulosin Use in Benign Prostatic Hyperplasia and Risks of Parkinson’s Disease, Alzheimer’s Disease and Mortality: An Observational Cohort Study of Elderly Medicare Enrollees.” PloS One 19 (8): e0309222. doi:10.1371/journal.pone.0309222.